The sports category has moved to a new website.

GSK calls for research proposals into non-communicable diseases (NCDs) in Kenya and across Sub-Saharan Africa

11 November 2016, Nairobi-Kenya: GlaxoSmithKline (GSK) announced the third call for proposals as part of the Africa NCD Open Lab this week, strengthening the company’s commitment to much-needed scientific research into NCDs.

___5744374___https:______static.pulse.com.gh___webservice___escenic___binary___5744374___2016___11___11___15___glaxosmith

The Africa NCD Open Lab is part of a series of investments GSK is making across Sub-Saharan Africa. The Open Lab, launched in 2014, aims to work in partnership with African researchers and academic groups to conduct research into NCDs such as cancer, diabetes, cardiovascular diseaseand chronic respiratory diseases.

NCDs were estimated to account for over one quarter (27%) of total deaths in Kenya in 2014, and across the country the probability of dying at a young age (between age 30 and 70 years) from an NCD is 18%. [i]NCDs cause over half of all reported adult deaths in some African countries, suggesting that NCDs could become a leading cause of health issues, disability and premature death.

[ii]The third call for research proposals to address these growing challenges is open from 7November 2016 until 12January 2017 and successful applicants will be awarded £100,000 for up to two years, along with scientific support from GSK.

It is hoped that the vital research conducted by scientists across the continent will improve the understanding of NCDs, and inform best practice prevention and treatment strategies.

ADVERTISEMENT

William Mwiti, Medical Director, GSK Pharmaceuticals Kenya Limited, said “Whilst huge progress has been made in recent years to understand and combat infectious diseases, more work needs to be done to tackle the growing health concern presented by NCDs in Kenya and across Sub-Saharan Africa. When an issue is better understood it can be more effectively tackled. By collaborating with our research network across Africa through the Open Lab, Kenyan scientists can work to vastly improve our understanding ofNCDs in Kenya and beyond.”

Dr. Mike Strange, Vice President and Head of Africa NCD Open Lab, said:

“GSK is committed to tackling the huge burden that NCDs place on patients, communities and health systems in Kenya and across Sub-Saharan Africa. The Open Labsupports our efforts to address these challenges.I encourage scientists to consider applying for the funding and support that the program offers and work to help us better understand NCD types across Africa.”

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: news@pulselive.co.ke

Recommended articles

For Guys: Outfits that instantly make you attractive & are easy to pull off

For Guys: Outfits that instantly make you attractive & are easy to pull off

Whole stuffed chicken recipe you can make for Easter

Whole stuffed chicken recipe you can make for Easter

Understanding delay rings, how they work & safety measures when using them

Understanding delay rings, how they work & safety measures when using them

Ex-cop Linda Okello acquires 2nd lavish home in the U.S.

Ex-cop Linda Okello acquires 2nd lavish home in the U.S.

10 essential parenting tips all first-time fathers should know

10 essential parenting tips all first-time fathers should know

15 Foods That Help Improve Erections

15 Foods That Help Improve Erections

10 unique ideas to gifting car enthusiasts on their special days

10 unique ideas to gifting car enthusiasts on their special days

10 important things to consider before getting a fire extinguisher

10 important things to consider before getting a fire extinguisher

Here's why dates begin Iftar meals during Ramadhan

Here's why dates begin Iftar meals during Ramadhan

ADVERTISEMENT